After elucidating the molecular mechanism of β-arrestin 2 (ARRB2), we generated ARRB2-knockout (ARRB2KO) lung cancer cells using CRISPR/Cas9 gene-editing method (two vector-based systems, Fig. 1B) [24]. The gene discussed is ARRB2; the disease is lung carcinoma.